Navigation Links
Florida's Leading Fertility Center Announces Successful Baby Delivery via Egg Freezing
Date:3/15/2012

ORLANDO, Fla., March 15, 2012 /PRNewswire/ -- The Center for Reproductive Medicine (CRM) announced today another successful healthy baby delivery from Egg Freezing. The procedure requires a woman's eggs (Oocytes) to be retrieved and then frozen via state-of-the-art technique, called vitrification.

(Logo:  http://photos.prnewswire.com/prnh/20120315/FL70989LOGO )  

The technique utilizes a fast-freezing process that eliminates ice crystals on the egg that could severely damage the egg's chromosomes when thawed. This approach eliminates the drawback of ice crystals which has hindered egg freezing procedures in the past.

The first successful baby delivery by CRM of a vitrified egg was in July of 2011.  CRM is offering egg freezing for women diagnosed with cancer who want to preserve their fertility prior to cancer therapy, patients suffering from chronic diseases (such as endometriosis), and for other reasons. 

Dr. Sejal Dharia Patel, states, "About 130,000 Americans under the age of 45 are diagnosed with cancer each year and approximately 70,000 of them are women. We have been very pleased with our initial success in our fertility preservation program and look forward to continued success as the indication expands."

Dr. Patel, goes on to say, "Women have a precious window of time to protect their chances for a future family. Egg freezing may help to expand that time window. The team at CRM is dedicated in providing the most comprehensive information and optimized fertility treatment care suited for the specific needs of these patients."

About Fertility Preservation via Vitrification
The vitrification technique is a relatively new procedure and is considered to be experimental according to the American Society for Reproductive Medicine, however, successful outcomes relating to the procedure have been reported from numerous centers across the Country. As of 2011, over 1000 babies have been born worldwide from egg freezing.

About The Center for Reproductive Medicine (CRM) - CRM has been a leading IVF and Infertility Center in Orlando and Central Florida since 1985. Combining decades of experience with state-of-the-art technology, CRM has achieved some of the highest success rates in the Southeast. CRM is also known for providing compassionate patient care, individualized treatment plans, and the most cost-efficient options, giving you every conceivable chance for success.

The Center for Reproductive Medicine's five infertility specialists share more than 90 years of combined experience and are nationally recognized as leaders in the field of reproductive medicine. Whether helping to conceive Central Florida's first IVF baby or performing robotic and minimally-invasive reproductive surgeries, CRM has always been on the leading edge of technology. For additional information, visit www.ivforlando.com.


'/>"/>
SOURCE Center for Reproductive Medicine
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Canopus Biopharma and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic
2. Leading Biopharmas Will Deliver Case Studies on Achieving Productivity Excellence through Engagement, Technology, Other Tools
3. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
4. Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche
5. Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service
6. ThalesNano, Inc. Forms Collaborations with Leading US Universities based on the Award Winning H-Cube(R) and H-Cube Midi(TM)
7. CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team
8. Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado
9. Leading Heart Specialist Joins Duska Therapeutics as Scientific Consultant
10. Patent Technologies Keep CGMT in a Leading Position in the Industry
11. MGuard(TM), InspireMDs Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... Kurzlehrgang mit Fokus auf Assay zum ... metaproteomische Analyse des Darm-Mikrobioms bei Säuglingen dar   ... Wie ... Peretz , Scientific Director bei ImmuneCarta, einen Kurzlehrgang zu ... intrazellulärer Zytokine bei adoptiven Zelltherapie-Studien im Rahmen der jährlich ...
(Date:2/17/2017)... India , February 17, 2017 ... report "Biomarkers Market by Product (Consumables, Service), Type ... Application (Diagnostics Development, Drug Discovery and Development, Disease-Risk) ... the market is projected to reach USD 53.34 ... 2016, growing at a CAGR of 13.8% during ...
(Date:2/17/2017)... Feb. 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: ... its oral peptide drug candidates, PTG-100 and PTG-200, ... European Crohn,s and Colitis Organization (ECCO).  The ECCO ... Spain from February 15 – 18, ... data on Protagonist drug candidates PTG-100 and PTG-200. ...
(Date:2/16/2017)... and GREENWICH, Conn. , ... investment firm focused on venture growth investments in ... of Josh Richardson , M.D. to Managing ... in biotechnology companies.  He is a board observer ... roles in Longitude,s investments in Aimmune Therapeutics, Akebia ...
Breaking Biology Technology:
(Date:2/8/2017)... YORK , Feb. 8, 2017 About ... individual,s voice to match it against a stored ... such as pitch, cadence, and tone are compared ... require minimal hardware installation, as most PCs already ... for different transactions. Voice recognition biometrics are most ...
(Date:2/8/2017)... Report Highlights ... The global synthetic-biology market reached nearly $3.9 ... growing at a compound annual growth rate (CAGR) of 24.0% ... global markets for synthetic biology. - Analyses of global market ... of compound annual growth rates (CAGRs) through 2021. - Coverage ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... billion by 2021 from $8.3 billion in 2016 at ... 2016 to 2021. Report Includes - An overview ... global market trends, with data from 2015 and 2016, ... 2021. - Segmentation of the market on the basis ...
Breaking Biology News(10 mins):